Globus Medical shares gain on its better-than-forecast 3rd quarter as the orthopedics company announces the surprise resignation of CFO Richard Baron.
NuVasive swings to a 3rd-quarter loss on higher-than-expected taxes, but beats Wall Street's sales expectations and says it expects to recoup the loss next quarter.
HeartWare posts narrowed 3rd-quarter losses thanks to increased sales of its implantable heart pumps in the U.S.
HeartWare International (NSDQ:HTWR) yesterday reported narrowed 3rd-quarter losses and significantly higher revenues, boosted by a 39% jump in U.S. sales of its implantable heart pumps.
Coloplast posts its 1st profits decline in 7 years on mounting legal costs stemming from U.S. product liability lawsuits filed over its pelvic mesh products.
Shares of Smith & Nephew are up today on solid 3rd-quarter results, including 6% growth for its U.S. hip implant business.
Abiomed says it's come to an agreement with the FDA on an indication for its flagship Impella 2.5 heart pump, and now expects to win pre-market approval early next year without a hearing before an FDA advisory panel.
Alere says it plans to sell its health-management unit to Optum for $600 million in cash in order to focus on its core rapid diagnostics business.
Alere agreed to sell Alere Health, its health-management unit, to health-services provider Optum for $600 million in cash in order to focus on its core rapid diagnostics business.